Two Sigma Investments’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.12M | Buy |
812,360
+432,779
| +114% | +$4.86M | 0.02% | 842 |
|
|
2025
Q1 | $1.73M | Sell |
379,581
-190,723
| -33% | -$872K | ﹤0.01% | 1785 |
|
|
2024
Q4 | $3.22M | Buy |
570,304
+140,030
| +33% | +$790K | 0.01% | 1347 |
|
|
2024
Q3 | $2.08M | Sell |
430,274
-177,199
| -29% | -$858K | ﹤0.01% | 1605 |
|
|
2024
Q2 | $2.96M | Buy |
607,473
+361,891
| +147% | +$1.77M | 0.01% | 1233 |
|
|
2024
Q1 | $3.26M | Buy |
245,582
+169,069
| +221% | +$2.25M | 0.01% | 1141 |
|
|
2023
Q4 | $1.07M | Buy |
+76,513
| New | +$1.07M | ﹤0.01% | 1962 |
|
|
2023
Q2 | – | Sell |
-141,756
| Closed | -$2.04M | – | 3191 |
|
|
2023
Q1 | $2.04M | Buy |
+141,756
| New | +$2.04M | 0.01% | 1301 |
|
|
2022
Q3 | – | Sell |
-56,781
| Closed | -$868K | – | 2787 |
|
|
2022
Q2 | $868K | Buy |
56,781
+29,187
| +106% | +$446K | ﹤0.01% | 1551 |
|
|
2022
Q1 | $630K | Buy |
+27,594
| New | +$630K | ﹤0.01% | 1871 |
|